Biologics for chronic rhinosinusitis with nasal polyps
Bachert C, et al.
J Allergy Clin Immunol · 2020
Key Findings
- ●Comprehensive review of biologic mechanisms
- ●Comparison of dupilumab, omalizumab, mepolizumab efficacy
- ●Endotype-based treatment selection
Referenced in (1 disease)
Validation history
Full log →No validation events recorded yet. Source will be checked on the next kipine-source-validator run.
ID: doi-10-1016-j-jaci-2020-07-032DOI: 10.1016/j.jaci.2020.07.032